Compare AbCellera Biologics Inc (ABCL) vs Danaos Corporation (DAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Danaos Corporation — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Danaos Corporation trades at $135.01 (market cap $2.46B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap, and Danaos Corporation pays a 2.67% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | DAC | |
|---|---|---|
Market Cap | $2.99B | $2.46B |
Sector | Health | Technology |
52-Week High | $9.76 | $143.15 |
52-Week Low | $2.78 | $84.05 |
Enterprise Value | $2.58B | $2.44B |
Dividend Yield | — | 2.67% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Danaos Corporation
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →
